Registration country:United Kingdom
Developed a unique technology that is used in the formulation of biopharmaceuticals.
Arecor has developed a unique technology that is used in the formulation of biopharmaceuticals. The company’s product, Arestat™, can stabilise protein-based drugs and vaccines from degradation associated with long-term storage or ionising radiation used in sterilisation. Arecor is collaborating with a number of pharmaceutical and biotech companies to develop recombinant proteins and vaccines for application in drugs, medical devices and diagnostics.